The potential prognostic clinicopathologic factors and the expressions of Nu-IL4Rα, Cy-IL4Rα, Nu-IL13Rα1, and Cy-IL13Rα1 were evaluated for their impact on OS and RFS of gallbladder carcinoma patients. This evidence concerns the gene IL13RA1 and gallbladder carcinoma.